How Quickly the Brain Breaks Down Different Opioid Peptides — Shorter Ones Degrade Faster | Research

The takeaway

Human spinal fluid contains an enzyme (aminopeptidase M) that degrades opioid peptides at rates inversely proportional to their length — enkephalins break down 13x faster than dynorphin A.

13x faster degradation for enkephalins
Aminopeptidase M in human CSF breaks down met-enkephalin 13 times faster than the longer dynorphin A peptide

What the researchers found

Aminopeptidase M in human CSF degrades opioid peptides at rates inversely proportional to chain length. Met-enkephalin is degraded ~13x faster than dynorphin A.

Why it matters

This explains why different opioid peptides last different amounts of time in the brain. Short peptides like enkephalins have brief signals, while longer peptides persist longer.

How the study worked

Human CSF aminopeptidase activity was measured using naphthylamide substrates and radiolabeled peptides. Inhibitor profiles, kinetics, and chain-length dependence were characterized.

What this study cannot tell us

In-vitro study of CSF enzyme activity. Actual opioid peptide lifetimes in living brain tissue depend on many additional factors beyond CSF aminopeptidase.

How to read the evidence

Moderate-strength in-vitro study using human CSF samples with thorough enzyme characterization. Directly relevant to human biology.

When this study was published

Published in 1990. The aminopeptidase degradation pathway has been confirmed and remains a key consideration in peptide drug design.

The bigger picture

Understanding peptide degradation rates is fundamental to designing peptide-based drugs. This study explained why natural enkephalins are poor drug candidates (they break down too fast) and informed the development of enzyme-resistant peptide analogs and enzyme inhibitors for pain management.

Questions still open

Could aminopeptidase inhibitors extend opioid peptide signaling for pain relief?
Do CSF aminopeptidase levels change in chronic pain conditions?

Common questions

Why do shorter peptides break down faster?

Aminopeptidase M clips amino acids from the end of peptides. Shorter peptides have their functional core (the Tyr-Gly bond) more exposed, so the enzyme reaches it faster. Longer peptides are somewhat protected by their extra length.

What does this mean for peptide-based pain treatments?

Natural opioid peptides are broken down too quickly to be useful as drugs. This study helped explain why, and guided the development of enzyme-resistant peptide modifications and enzyme inhibitors that could extend peptide activity for pain relief.

Read the original research

N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid.

Biochemical pharmacology, 40(3), 465-72

View on PubMed ↗

Citation

Benter, I F; Hirsh, E M; Tuchman, A J; Ward, P E. (1990). N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid.. Biochemical pharmacology, 40(3), 465-72.